Background illustration for clinical trials search

Triple Negative Breast Cancer Clinical Trials

Browse 2,256 triple negative breast cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

VST-1001 (Dilute Fluorescein) for Lymphatic Mapping & Localization of Lymph Nodes in Patients With Breast Cancer

for
Breast Cancer
Location: Houston TX, Salt Lake City UT
Sponsor: Vestan, Inc.

Sex: All

Age: 18+

Code: NCT02294565

Phase 1, Phase 2, Recruiting

A Pilot Study To Evaluate the Effectiveness of Pulsed Time-Domain Optical Spectroscopy for Monitoring the Responses in Neoadjuvant Treatments of Locally-Advanced Breast Cancer

for
Breast Cancer
Location: Toronto
Sponsor: Sunnybrook Health Sciences Centre

Sex: Female

Age: 20 - 70+

Code: NCT00438074

Recruiting

Promoting Access, Resources and Treatment Through Novel and Equitable Solutions for Cancer Care

for
Cancer
Location: Cleveland OH
Sponsor: Case Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT06481774

Recruiting

International Rare Brain Tumor Registry

for
Astroblastoma, BCOR ITD Sarcoma, CNS Sarcoma,
Location: Washington D.C. DC, Akron OH, Cincinnati OH, Chicago IL,
Sponsor: Children's National Research Institute

Sex: All

Age: 0 - 45

Code: NCT05697874

Recruiting

Manual Lymphatic Drainage Breast Massage in Breast Cancer Patients After Breast Conserving Surgery

for
Anatomic Stage 0 Breast Cancer AJCC v8,
Location: Los Angeles CA
Sponsor: University of Southern California

Sex: Female

Age: 18+

Code: NCT06297265

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of NX-1607 in Adults With Advanced Malignancies

for
Ovarian Cancer, Epithelial, Gastric Cancer,
Location: Charlottesville VA, Chapel Hill NC, Chicago IL,
Sponsor: Nurix Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05107674

Phase 1, Recruiting

Establish ProLung Test Measurement Collection Protocol for Future Studies.

for
Cancer , Healthy
Location: Maywood IL, Ogden UT, Salt Lake City UT, Encinitas CA
Sponsor: Fresh Medical Laboratories

Sex: All

Age: 18+

Code: NCT04134520

Recruiting

EMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancers

for
Neoplasms, Neoplasm Metastasis,
Location: Houston TX
Sponsor: Shanghai EpimAb Biotherapeutics Co., Ltd.

Sex: All

Age: 18+

Code: NCT05176665

Phase 1, Phase 2, Recruiting

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

for
Locally Advanced Solid Tumor
Location: Boston MA, New York NY, Fairfax VA, Miami FL,
Sponsor: Tango Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05732831

Phase 1, Phase 2, Recruiting

Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer

for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT04329065

Phase 2, Recruiting

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

for
Metastatic Breast Cancer, Metastatic Gastric Adenocarcinoma,
Location: Boston MA, Shirley NY, New Haven CT, New York NY,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT06324357

Phase 1, Phase 2, Recruiting

E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers

for
Cervical Cancer, Throat Cancer, Oropharynx Cancer, Anal Cancer,
Location: New Brunswick NJ, Bethesda MD
Sponsor: Christian Hinrichs

Sex: All

Age: 18+

Code: NCT05686226

Phase 2, Recruiting

Integrated Patient Avatars for Guiding Systemic Therapy Treatments in Metastatic Breast Cancer Patients

for
Breast Cancer, Breast Neoplasms, Metastatic Breast Cancer,
Location: Toronto
Sponsor: Sunnybrook Health Sciences Centre

Sex: All

Age: 18+

Code: NCT04608357

Recruiting

The PREDICT Registry:

for
DCIS, Stage 0 Breast Cancer, Ductal Breast Carcinoma In Situ
Location: Boston MA, Mineola NY, Lake Success NY, New York NY,
Sponsor: PreludeDx

Sex: Female

Age: 30 - 70+

Code: NCT03448926

Recruiting

AOH1996 for the Treatment of Refractory Solid Tumors

for
Refractory Malignant Solid Neoplasm, Osteosarcoma,
Location: Duarte CA, Long Beach CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT05227326

Phase 1, Recruiting

Discovering Novel Cancer Treatment Options Using a Comprehensive NGS-based Molecular Testing Panel in the Community Setting ("DINOSAur")

for
Stage III Solid Tumors, Stage IV Solid Tumors
Location: Glendale CA
Sponsor: Glendale Adventist Medical Center d/b/a Adventist Health Glendale

Sex: All

Age: 18+

Code: NCT05692466

Recruiting

Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort

for
Invasive Mammary Carcinoma, Metastatic Breast Cancer
Location: Birmingham AL, Nashville TN, Memphis TN, Dallas TX
Sponsor: Sonya Reid

Sex: All

Age: 18+

Code: NCT05693766

Phase 2, Recruiting

[18F] F-GLN by PET/CT in Breast Cancer

for
Breast Cancer
Location: Philadelphia PA
Sponsor: Abramson Cancer Center at Penn Medicine

Sex: All

Age: 18+

Code: NCT03863457

Phase 1, Recruiting

Genomic Services Research Program

for
Colon Cancer, Breast Cancer
Location: Bethesda MD
Sponsor: National Human Genome Research Institute (NHGRI)

Sex: All

Age: 0 - 70+

Code: NCT02595957

Recruiting

BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)

for
Advanced Malignancies, Ovarian Cancer, T-cell Lymphoma,
Location: New York NY, Philadelphia PA, Duarte CA
Sponsor: BioInvent International AB

Sex: All

Age: 18+

Code: NCT04752826

Phase 1, Phase 2, Recruiting

What is triple negative breast cancer?

Triple negative breast cancer, or TNBC, is breast cancer whose cells test negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so hormone therapy and HER2 targeted drugs do not work against it. It tends to grow faster and is more common in women who have not gone through menopause, in Black women, and in people with an inherited BRCA1 mutation, so genetic testing is recommended for everyone diagnosed. In US data, five year relative survival is about 92 percent when it is found while localized, 67 percent with regional spread, and 15 percent once it has reached distant organs. Standard treatment for early stage disease is chemotherapy combined with immunotherapy before surgery, followed by more treatment after; metastatic disease is treated with chemotherapy, immunotherapy for PD-L1 positive tumors, and antibody drug conjugates. Other breast cancers are covered on our breast cancer clinical trials page.

Types of triple negative breast cancer clinical trials

Who can participate in triple negative breast cancer clinical trials?

Is triple negative breast cancer hereditary?

Stages of triple negative breast cancer, and why they matter for trials

How to enroll in a triple negative breast cancer clinical trial